St. Louis Pharmaceutical Slashes Price Following Outcry

View Comments

CBS St. Louis (con't)

Affordable Care Act Updates: CBSStL.com/ACA

Health News & Information: CBSStL.com/Health

ST. LOUIS (KMOX) – A St. Louis-based pharmaceutical company is slashing the price on a drug to prevent premature births following public outcry over the high cost.  

KV Pharmaceutical is dropping the cost from $1,500 dollars to $690 dollars for a weekly injection of the drug Makena. 

The action comes after the Food and Drug Administration announced it would not stop specialty pharmacies from continuing to make a generic version of the drug that had been selling for as little as ten dollars. 

Friday, the March of Dimes announced it was severing all ties with the KV subsidiary that is marketing the drug.

Copyright KMOX News

View Comments
blog comments powered by Disqus